Yes, targeted medical weight loss is often a game-changer for these conditions
In this narrative literature review, we explore the pharmacological properties of tirzepatide and critically summarize and comment on the results of the clinical studies conducted thus far, as well as discuss the potential implications for the treatment of obesity, T2DM, and associated cardiometabolic complications
have investigated the potential association between GLP-1 RAs, DPP-4 inhibitors, and biliary diseases utilizing the Food and Drug Administration Adverse Event Reporting System (FAERS) database
Yet the real-world data tells a different story
Are Natural GLP-1 Alternatives Safe for Everyone
Dietary and lifestyle changes can help minimize these side effects